MIZUKAMI; Tamio
Patent Applications and Registrations
Patent applications and USPTO patent grants for MIZUKAMI; Tamio.The latest application filed is for "image processing method, drug sensitivity test method and image processing apparatus".
- MIZUKAMI; Tamio - Shiga JP
- Mizukami; Tamio - Nagaokakyo-shi JP
- Mizukami; Tamio - Nagaokakyo JP
- Mizukami; Tamio - Nagahama JP
- MIZUKAMI; Tamio - Nagahama-shi Shiga
- Mizukami, Tamio - Machida-shi JP
- Mizukami, Tamio - Tokyo JP
- Mizukami; Tamio - Chiyoda-Ku JP
- Mizukami; Tamio - Machida JP
- Mizukami; Tamio - Bethesda MD
| Patent | Date |
|---|---|
| Image Processing Method, Drug Sensitivity Test Method And Image Processing Apparatus App 20210224992 - MIZUKAMI; Tamio ; et al. | 2021-07-22 |
| Metallic Porous Membrane, Classifying Method Using The Same, And Classifying Device App 20210071132 - Kondo; Takashi ; et al. | 2021-03-11 |
| Metallic porous membrane, classifying method using the same, and classifying device Grant 10,889,796 - Kondo , et al. January 12, 2 | 2021-01-12 |
| Metallic Porous Membrane, Classifying Method Using The Same, And Classifying Device App 20180362917 - Kondo; Takashi ; et al. | 2018-12-20 |
| LSD1-selective inhibitor having lysine structure Grant 9,388,123 - Suzuki , et al. July 12, 2 | 2016-07-12 |
| Lsd1-selective Inhibitor Having Lysine Structure App 20160039748 - SUZUKI; Takayoshi ; et al. | 2016-02-11 |
| E2F activity-inhibiting compound App 20050137138 - Shibata, Kenji ; et al. | 2005-06-23 |
| Indole derivative App 20050070591 - Kanai, Fumihiko ; et al. | 2005-03-31 |
| UCS1025 derivatives Grant 6,869,971 - Akama , et al. March 22, 2 | 2005-03-22 |
| E2F activity inhibitory compounds Grant 6,713,449 - Shibata , et al. March 30, 2 | 2004-03-30 |
| Bisaryl compound and medicament for cancer treatment comprising the same App 20030199560 - Yonetani, Yoshiyuki ; et al. | 2003-10-23 |
| Bisaryl compound and medicament for cancer treatment comprising the same Grant 6,608,061 - Yonetani , et al. August 19, 2 | 2003-08-19 |
| Bisaryl Compound And Medicament For Cancer Treatment Comprising The Same App 20030018070 - YONETANI, YOSHIYUKI ; et al. | 2003-01-23 |
| Farnesyltransferase inhibitor Grant 5,925,641 - Kanda , et al. July 20, 1 | 1999-07-20 |
| UCS1025 compounds Grant 5,798,379 - Mizukami , et al. August 25, 1 | 1998-08-25 |
| Farnesyltransferase inhibitor Grant 5,728,830 - Kanda , et al. March 17, 1 | 1998-03-17 |
| Cytotoxic agent against specific virus infection Grant 5,587,455 - Berger , et al. December 24, 1 | 1996-12-24 |
| Amino acid synthesis in corynebacteria using E. coli genes Grant 5,236,831 - Katsumata , et al. August 17, 1 | 1993-08-17 |
| CD-4/cytotoxic gene fusions Grant 5,206,353 - Berger , et al. April 27, 1 | 1993-04-27 |
| Fish growth hormone polypeptide Grant 4,849,359 - Sekine , et al. July 18, 1 | 1989-07-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 